Your browser doesn't support javascript.
loading
Prediction of tissue-of-origin of early stage cancers using serum miRNomes.
Matsuzaki, Juntaro; Kato, Ken; Oono, Kenta; Tsuchiya, Naoto; Sudo, Kazuki; Shimomura, Akihiko; Tamura, Kenji; Shiino, Sho; Kinoshita, Takayuki; Daiko, Hiroyuki; Wada, Takeyuki; Katai, Hitoshi; Ochiai, Hiroki; Kanemitsu, Yukihide; Takamaru, Hiroyuki; Abe, Seiichiro; Saito, Yutaka; Boku, Narikazu; Kondo, Shunsuke; Ueno, Hideki; Okusaka, Takuji; Shimada, Kazuaki; Ohe, Yuichiro; Asakura, Keisuke; Yoshida, Yukihiro; Watanabe, Shun-Ichi; Asano, Naofumi; Kawai, Akira; Ohno, Makoto; Narita, Yoshitaka; Ishikawa, Mitsuya; Kato, Tomoyasu; Fujimoto, Hiroyuki; Niida, Shumpei; Sakamoto, Hiromi; Takizawa, Satoko; Akiba, Takuya; Okanohara, Daisuke; Shiraishi, Kouya; Kohno, Takashi; Takeshita, Fumitaka; Nakagama, Hitoshi; Ota, Nobuyuki; Ochiya, Takahiro.
Affiliation
  • Matsuzaki J; Division of Molecular and Cellular Medicine, National Cancer Center Research Institute, Chuo-ku, Tokyo, Japan.
  • Kato K; Division of Pharmacotherapeutics, Keio University Faculty of Pharmacy, Minato-ku, Tokyo, Japan.
  • Oono K; Department of Head and Neck, Esophageal Medical Oncology and Department of Gastrointestinal Medical Oncology, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan.
  • Tsuchiya N; Preferred Networks, Inc, Chiyoda-ku, Tokyo, Japan.
  • Sudo K; Laboratory of Molecular Carcinogenesis, National Cancer Center Research Institute, Chuo-ku, Tokyo, Japan.
  • Shimomura A; Department of Breast and Medical Oncology, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan.
  • Tamura K; Department of Breast and Medical Oncology, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan.
  • Shiino S; Department of Breast and Medical Oncology, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan.
  • Kinoshita T; Department of Breast Surgery, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan.
  • Daiko H; Department of Breast Surgery, National Hospital Organization Tokyo Medical Center, Meguro-ku, Tokyo, Japan.
  • Wada T; Department of Esophageal Surgery, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan.
  • Katai H; Department of Gastric Surgery, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan.
  • Ochiai H; Department of Gastric Surgery, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan.
  • Kanemitsu Y; Department of Colorectal Surgery, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan.
  • Takamaru H; Department of Colorectal Surgery, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan.
  • Abe S; Endoscopy Division, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan.
  • Saito Y; Endoscopy Division, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan.
  • Boku N; Endoscopy Division, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan.
  • Kondo S; Department of Head and Neck, Esophageal Medical Oncology and Department of Gastrointestinal Medical Oncology, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan.
  • Ueno H; Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan.
  • Okusaka T; Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan.
  • Shimada K; Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan.
  • Ohe Y; Department of Hepatobiliary and Pancreatic Surgery, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan.
  • Asakura K; Department of Thoracic Oncology, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan.
  • Yoshida Y; Department of Thoracic Surgery, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan.
  • Watanabe SI; Department of Thoracic Surgery, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan.
  • Asano N; Department of Thoracic Surgery, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan.
  • Kawai A; Department of Musculoskeletal Oncology, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan.
  • Ohno M; Department of Musculoskeletal Oncology, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan.
  • Narita Y; Department of Neurosurgery and Neuro-Oncology, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan.
  • Ishikawa M; Department of Neurosurgery and Neuro-Oncology, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan.
  • Kato T; Department of Gynecology, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan.
  • Fujimoto H; Department of Gynecology, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan.
  • Niida S; Department of Urology, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan.
  • Sakamoto H; Research Institute, National Center for Geriatrics and Gerontology, Obu, Aichi, Japan.
  • Takizawa S; Department of Biobank and Tissue Resources, Fundamental Innovative Oncology Core, National Cancer Center Research Institute, Chuo-ku, Tokyo, Japan.
  • Akiba T; Division of Molecular and Cellular Medicine, National Cancer Center Research Institute, Chuo-ku, Tokyo, Japan.
  • Okanohara D; Toray Industries, Inc, Kamakura, Kanagawa, Japan.
  • Shiraishi K; Preferred Networks, Inc, Chiyoda-ku, Tokyo, Japan.
  • Kohno T; Preferred Networks, Inc, Chiyoda-ku, Tokyo, Japan.
  • Takeshita F; Division of Genome Biology, National Cancer Center Research Institute, Chuo-ku, Tokyo, Japan.
  • Nakagama H; Division of Genome Biology, National Cancer Center Research Institute, Chuo-ku, Tokyo, Japan.
  • Ota N; Department of Translational Oncology, Fundamental Innovative Oncology Core, National Cancer Center Research Institute, Chuo-ku, Tokyo, Japan.
  • Ochiya T; National Cancer Center, Chuo-ku, Tokyo, Japan.
JNCI Cancer Spectr ; 7(1)2023 01 03.
Article in En | MEDLINE | ID: mdl-36426871

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: MicroRNAs / Neoplasms Type of study: Prognostic_studies / Risk_factors_studies / Screening_studies Limits: Humans Language: En Journal: JNCI Cancer Spectr Year: 2023 Document type: Article Affiliation country: Japón Country of publication: Reino Unido

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: MicroRNAs / Neoplasms Type of study: Prognostic_studies / Risk_factors_studies / Screening_studies Limits: Humans Language: En Journal: JNCI Cancer Spectr Year: 2023 Document type: Article Affiliation country: Japón Country of publication: Reino Unido